Status: Recruiting
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.
Participants needed: 4,975
Trial details
Age: 12+Biological sex: AllType: ObservationalSponsor: European Organisation for Research and Treatment of Cancer - EORTCUpdated: Jun 24, 2026Locations: 136Duration: 5 Years
Eligibility criteria
Patients with pathologically confirmed selected tumor types (at site or centrall... [+5]